Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
miR-18a–ALOXE3 Axis in Glioblastoma
2026-08-27
The reference study identifies a miR-18a–ALOXE3 axis that promotes glioblastoma by reducing ferroptotic vulnerability and enhancing tumor-cell migration. Its integrated human-tissue, cellular, lipid-mediator, and orthotopic-mouse experiments connect lipid metabolism with p53–SLC7A11-dependent ferroptosis and GsPCR–PI3K–Akt signaling.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-27
The reference study identifies CD44 as a functional metabolic dependency in IDH-mutant leukemia, connecting adhesion signaling with pentose phosphate pathway activity, NADPH generation, and R-2HG production. Its isogenic CRISPR-based design supports combined CD44 and mutant-IDH targeting as a mechanistically informed strategy, although clinical translation remains to be established.
-
Ruxolitinib: Mapping Cytokine-Signaling Control
2026-08-26
Ruxolitinib (INCB018424) offers a precise way to distinguish proximal innate immune sensing from downstream cytokine amplification. This article integrates JAK1/2 pharmacology with neonatal monocyte evidence to improve assay design for inflammation, myelofibrosis, and myeloproliferative disorder research.
-
hCG, H3K27 Methylation, and CXCL10 in Decidua
2026-08-26
The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells through EZH2-associated deposition of repressive H3K27me3 at the CXCL10 promoter. This hormone-to-chromatin mechanism links placental signaling with selective control of CD8 T-cell recruitment at the maternal–fetal interface and provides a useful framework for studying epigenetic regulation of immune communication.
-
WZ4003 Lowers Tau Ser356 in Alzheimer’s Brain
2026-08-25
Taylor et al. link tau phosphorylation at Ser356 with Alzheimer’s disease progression, neurofibrillary tangles, and synaptic localization. Their ex vivo experiments further show that the NUAK1/2 inhibitor WZ4003 lowers p-tau Ser356 in live human brain slices, while mouse slice cultures display a broader, culture-dependent loss of tau and neuronal proteins.
-
HNRNPU K181 Lactylation Reprograms Cervical Cancer
2026-08-25
This Advanced Science study identifies HNRNPU K181 lactylation as a lactate-responsive mechanism that stabilizes HNRNPU, preserves PHGDH mRNA, and activates serine biosynthesis in cervical cancer. Its integration of public datasets, post-transcriptional mechanism analysis, functional models, and pharmacological perturbation clarifies how a non-histone modification can connect tumor metabolism with cancer growth.
-
Biotin-XX Tyramide Reagent: 5 Lab Scenarios
2026-08-24
This scenario-based guide explains how Biotin-XX Tyramide Reagent, SKU A8012, can improve surface-restricted detection in tyramide signal amplification workflows. It covers assay compatibility, solvent handling, controls, interpretation, and practical vendor-selection criteria for biomedical laboratories.
-
Clodronate Liposomes in Macrophage Studies
2026-08-24
Clodronate Liposomes provide a practical way to test whether macrophages are causal drivers of tumor growth, immune checkpoint resistance, or tissue injury. This guide translates the CCL7–TAM findings in colorectal cancer into controlled depletion workflows, assay designs, and troubleshooting strategies.
-
Nutlin-3a MDM2 Inhibitor Workflow for p53 Studies
2026-08-23
Nutlin-3a provides a mechanism-focused way to activate p53, distinguish cell cycle arrest from apoptosis induction, and interrogate MDM2 biology in cancer models. This workflow extends its use into glioblastoma assays by pairing MDM2 inhibition with the ferroptosis and migration findings reported for the miR-18a–ALOXE3 axis.
-
Maternal Deltamethrin, p53 Ferroptosis, and Memory
2026-08-22
The reference study links maternal deltamethrin exposure during pregnancy and lactation to impaired hippocampal learning and memory in male rat offspring through a p53-associated ferroptosis pathway. Its combination of behavioral, histological, biochemical, and cell-based intervention data provides a mechanistic framework for studying developmental neurotoxicity and for testing carefully controlled p53 pathway perturbations.
-
N1-Methylpseudouridine: From Design to Disease Rescue
2026-08-22
N1-Methylpseudouridine links RNA sequence design, translational control, and disease-relevant phenotyping. This evidence-focused guide explains how modified nucleosides can improve mRNA translation enhancement while clarifying the assay controls needed to distinguish base effects from codon optimization.
-
Cyanine 5-dCTP: From Label to Assay Design
2026-08-20
Cyanine 5-dCTP enables direct red-fluorescent labeling of DNA through enzymatic nucleotide incorporation. This guide connects its molecular design with PCR, probe synthesis, microscopy, and the practical lessons of ordered DNA frameworks for more reliable assay decisions.
-
Balsalazide for Ulcerative Colitis: Evidence and Insight
2026-08-20
The reference review evaluates balsalazide as a bacteria-activated 5-aminosalicylate prodrug designed to deliver 5-ASA throughout the colon. Its analysis supports remission induction in mild-to-moderate active ulcerative colitis, with faster symptom improvement and a safety profile comparable to other oral 5-ASA therapies.
-
ATS-9R Workflow for Adipose Gene Delivery
2026-08-19
ATS-9R combines adipocyte-selective recognition with nona-arginine-mediated nucleic acid condensation for focused white adipose tissue experiments. This practical workflow covers complex formation, tissue-selective dosing, assay controls, and troubleshooting for metabolic disease research.
-
CTCF Maintains Centromere Function in Mitosis
2026-08-19
Walsh and colleagues use rapid, inducible CTCF degradation to show that CTCF supports centromere mechanics, metaphase chromosome alignment, and mitotic fidelity. The study separates this architectural role from CENP-E recruitment and provides a framework for distinguishing centromere maintenance defects from motor-protein inhibition in cancer research.